Portable receiver for displaying and storing measured values from the HemoPill® acute.

LATEST PRODUCTS

+49 (0) 7071 96528 160
service@ovesco.com

Range of application of the HemoPill® Receiver

The HemoPill® Receiver is a portable receiver for displaying and storing measured values from the HemoPill® acute. The measured values are transmitted wirelessly in real time from the HemoPill® acute to the HemoPill® Receiver.

The HemoPill® Receiver

The HemoPill® Receiver has a colour display with touchscreen. The menu navigation is straightforward and allows for easy data access. Due to the integrated battery, the HemoPill® Receiver is transportable and thus enables user-friendly handling.

The corresponding thermal printer (HemoPill® Printer) can be connected via the designated USB port on the side of the HemoPill® Receiver to print out the findings.

Please note: The HemoPill® acute is not for sale in the US.

Dimensions and specifications

The HemoPill® Receiver is used for displaying and storing measured values from the HemoPill® acute.

Operation Battery or power supply
Packaging unit 1 piece
Reference number 500.20

Accessories

HemoPill® Printer: Thermal printer for printing the HemoPill® acute findings. /

  • Connection to the HemoPill® Receiver via USB port
  • Print quality maintained for up to 25 years with special thermosensitive paper
Operation Power supply
Packaging unit 1 piece
Reference number 500.30

Application of the HemoPill® acute

Step 1: Switch on the HemoPill® Receiver
Step 2: Activate HemoPill® acute in the blister pack using the HemoPill® Receiver
Step 3: Establish a connection between HemoPill® acute and HemoPill® Receiver
Step 4: Take HemoPill® acute with a glass of water
Step 5: Interpret transmitted measured values (HemoPill® Indicator, HI) on the display of the HemoPill® Receiver: An HI value in the red range of the diagram means that liquid blood (or haematin) has been detected ->positive finding
Step 6: Print out the finding for the patient file if required

Application video

Example 1: Detection of acute bleeding in the stomach

20 minutes after swallowing the HemoPill® acute, a significant increase in the HI value was observed. This indicated acute bleeding in the upper digestive tract. The examination using the HemoPill® was completed after 43 minutes and a gastroscopy was performed immediately. This showed a bleeding angiodysplasia in a gastrojejunal anastomosis, which was successfully treated.

Example 2: Detection of bleeding in the small intestine

The significant increase in the HI value after 2.5 hours was indication of bleeding in the middle digestive tract. The examination took a total of 9 hours. A subsequent targeted double balloon enteroscopy showed angiodysplasia in the small intestine, which was treated successfully.

Use of the HemoPill® acute in the early clinical phase (July 2019 – September 2020)
Source: Prof. Dr. Arthur R. Schmidt and Dr. Armin Kuellmer, Medical Center – University of Freiburg, Germany / Prof. Dr. Juergen Hochberger and Dr. Thomas Brunk, Vivantes Klinikum im Friedrichshain, Germany

Example 1: Excluding upper GI bleeding

No increase in the HI value was observed after the capsule was swallowed. Further differential diagnostics identified an aortic dissection as the cause of the anaemia detected in the emergency room. This meant that the patient did not need to undergo an endoscopy.

Use of the HemoPill® acute in the early clinical phase (July 2019 – September 2020)
Source: Prof. Dr. Arthur R. Schmidt and Dr. Armin Kuellmer, Medical Center – University of Freiburg, Germany / Prof. Dr. Juergen Hochberger and Dr. Thomas Brunk, Vivantes Klinikum im Friedrichshain, Germany

Media

{{pluginSettings.generalSettings.writing.no_results}}
of {{actionSettings.pagesCount}}

Other products of the HemoPill® product family



Related products

TOP